The Ocular Microbiome in Patients With Dry Eye Disease
Identification of the Ocular Microbiome and Its Role on Dry Eye Disease
1 other identifier
observational
80
1 country
1
Brief Summary
The primary objective of this study is the characterization of the ocular microbiome in a healthy cohort and in patients with dry eye disease using whole-metagenome shotgun sequencing. Secondary objectives are the identification of differences between the ocular microbiome of healthy controls and patients with dry eye disease as well as between the ocular and the gut microbiome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2020
CompletedFirst Submitted
Initial submission to the registry
November 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 7, 2020
CompletedDecember 7, 2020
November 1, 2020
5 months
November 30, 2020
November 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Characterization of the ocular microbiome
at baseline
Secondary Outcomes (1)
Identification of differences of the ocular microbiome between patients and controls
at baseline
Study Arms (2)
Patients with dry eye disease
Healthy controls
Interventions
Taxonomical and functional characterization of the ocular microbiome
Eligibility Criteria
Consecutive ongoing recruitment of subjects attending routine follow-ups through the involved investigators in daily clinical practice at Department of Ophthalmology, Inselspital, Bern
You may qualify if:
- Patients willing to sign informed consent
- Patients 60 years of age or older
You may not qualify if:
- Patients not willing or able to sign informed consent
- Patients younger than 60 years
- Smoking
- Wearing contact lenses
- Recent (3 month) history of use of systemic and/or topical antibiotics
- Usage of medical eye drops (Lacrycon and other moisturizing eye drops are allowed)
- Recent (3 month) history of ocular surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology, Inselspital
Bern, 3010, Switzerland
Related Publications (1)
Zysset-Burri DC, Schlegel I, Lincke JB, Jaggi D, Keller I, Heller M, Lagache SB, Wolf S, Zinkernagel MS. Understanding the Interactions Between the Ocular Surface Microbiome and the Tear Proteome. Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):8. doi: 10.1167/iovs.62.10.8.
PMID: 34369983DERIVED
Biospecimen
DNA isolated from eye swabs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Zinkernagel, Prof. Dr. Dr.
Department of Ophthalmology, Inselspital, Bern
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2020
First Posted
December 7, 2020
Study Start
September 30, 2019
Primary Completion
March 4, 2020
Study Completion
March 4, 2020
Last Updated
December 7, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share